Company Filing History:
Years Active: 1997-1998
Title: Jan Birger Tornell: Innovator in Bile Salt-Stimulated Lipase Variants
Introduction
Jan Birger Tornell is a notable inventor based in Vastra Frolunda, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of variants of Bile Salt-Stimulated Lipase (BSSL). With a total of 4 patents to his name, Tornell's work has implications for both medical and agricultural applications.
Latest Patents
Tornell's latest patents include groundbreaking inventions related to nucleic acids encoding BSSL variants. The first patent discloses nucleic acids that encode variant BSSL enzymes, which maintain catalytic activity while containing fewer glycosylation sites than full-length BSSL. This reduced glycosylation facilitates the purification and characterization of recombinant BSSL proteins. The second patent focuses on transgenic non-human mammals that produce BSSL variants. This invention encompasses novel polypeptides, DNA molecules encoding these polypeptides, and processes for producing transgenic animals capable of expressing the BSSL variants. Additionally, it includes infant formulas derived from milk of such transgenic animals and pharmaceutical compositions containing the polypeptides.
Career Highlights
Throughout his career, Jan Birger Tornell has worked with prominent companies such as Astra Aktiebolag and Aktiebolaget Astra. His experience in these organizations has contributed to his expertise in biochemistry and patent development.
Collaborations
Tornell has collaborated with notable individuals in his field, including Stig Lennart Hansson and Lars Gustav Blackberg. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Jan Birger Tornell's contributions to the field of Bile Salt-Stimulated Lipase variants highlight his innovative spirit and dedication to advancing biochemistry. His patents pave the way for future developments in medical and agricultural applications.